Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The European Directive 2001/20 for clinical research: friend or foe?

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Veelo D, Spronk P, Kuiper M, Korevaar J, van der Voort P, Schultz M (2006) A change in the Dutch Directive on medical research involving human subjects strongly increases the number of eligible intensive care patients: an observational study. Intensive Care Med DOI 10.1007/s00134-006-0384-2

  2. 2.

    van Dijk Y, van der Voort P, Kuiper M, Kesecioglu J (2003) Research on subjects incapable of giving consent: the situation in Dutch intensive care departments. Intensive Care Med 20:2100–2101

  3. 3.

    Harvey SE, Elbourne D, Ashcroft J, Jones C, Rowan K (2006) Informed consent in clinical trials in crtitical care: experience from the PAC-man study. Intensive Care Med

  4. 4.

    van der Voort P, Kesecioglu J (2006) Changes in the Dutch law on medical research. Intensive Care Med DOI 10.1007/s00134-006-0385-1

  5. 5.

    Meunier F, Lacombe C (2003) European organisation for research and treatment of cancer's point of view. Lancet 362:663

  6. 6.

    Lemaire F, Bion J, Blanco J, Damas P, Druml C, Falke K, Kesecioglu J, Larsson A, Mancebo A, Matamis D, Pesenti A, Pimentel J, Ranieri M (2005) The EU directive on clinical research: present status of implementation in EU member states legislations with regard to the incompetent patient. Intensive Care Med 31:476–479

  7. 7.

    Menon DK, Liddell K (2004) Consent for research. J Intensive Care Soc 5:98–99

  8. 8.

    Coats TJ, Shakur H (2005) Consent in emergency research: new regulations. Emerg Med J 22:683–685

  9. 9.

    Sprumont D (1999) Legal protection of human research subjects in Europe. Eur J Health Law 6:25–43

  10. 10.

    Grimes DA, Hubacher D, Nanda K, Schulz KF, Moher D, Altman DG (2005) The good clinical practice guideline: a bronze standard for clinical research. Lancet 366:172–174

  11. 11.

    Lemaire F, Brun-Buisson C (2000) Are institutional review boards effective in safeguarding patients in ICU? Curr Op 13:195–201

  12. 12.

    Vlahakes GJ (2006) The value of phase 4 clinical testing. N Engl J Med 354:413–415

Download references

Author information

Correspondence to François Lemaire.

Additional information

This editorial refers to the articles available at: http://dx.doi.org/10.1007/s00134-006-0384-2 and http://dx.doi.org/10.1007/s00134-006-0385-1

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lemaire, F. The European Directive 2001/20 for clinical research: friend or foe?. Intensive Care Med 32, 1689–1690 (2006). https://doi.org/10.1007/s00134-006-0386-0

Download citation